Mycophenolate mofetil structure
|
Common Name | Mycophenolate mofetil | ||
---|---|---|---|---|
CAS Number | 128794-94-5 | Molecular Weight | 433.495 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 637.6±55.0 °C at 760 mmHg | |
Molecular Formula | C23H31NO7 | Melting Point | 95-96ºC | |
MSDS | Chinese USA | Flash Point | 339.4±31.5 °C | |
Symbol |
GHS07, GHS09 |
Signal Word | Warning |
Use of Mycophenolate mofetilMycophenolate Mofetil is a non-competitive, selective and reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH) with IC50s of 39 nM and 27 nM, respectively. |
Name | mycophenolate mofetil |
---|---|
Synonym | More Synonyms |
Description | Mycophenolate Mofetil is a non-competitive, selective and reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH) with IC50s of 39 nM and 27 nM, respectively. |
---|---|
Related Catalog | |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 637.6±55.0 °C at 760 mmHg |
Melting Point | 95-96ºC |
Molecular Formula | C23H31NO7 |
Molecular Weight | 433.495 |
Flash Point | 339.4±31.5 °C |
Exact Mass | 433.210052 |
PSA | 94.53000 |
LogP | 3.15 |
Vapour Pressure | 0.0±2.0 mmHg at 25°C |
Index of Refraction | 1.557 |
Storage condition | Store at RT |
Safety and efficacy of the early introduction of everolimus with reduced-exposure cyclosporine a in de novo kidney recipients.
Transplantation 99(1) , 180-6, (2015) Everolimus and cyclosporine A (CsA) exhibit synergistic immunosuppressive activity when used in combination. We examined the safety and efficacy of the use of everolimus with a cyclosporine-sparing st... |
|
Preemptive thoracic drainage to eradicate postoperative pulmonary complications after living donor liver transplantation.
J. Am. Coll. Surg. 219(6) , 1134-42.e2, (2014) Thoracic fluid retention after living donor liver transplantation (LDLT) has various negative consequences, including atelectasis, pneumonia, and respiratory distress or failure.We analyzed the clinic... |
|
The risk of recurrent IgA nephropathy in a steroid-free protocol and other modifying immunosuppression.
Clin. Transplant. 28(8) , 845-54, (2014) Recurrent glomerulonephritis is an important cause of kidney allograft failure. The effect of immunosuppression on recurrent IgA nephropathy (IgAN) is unclear. We analyzed the impact of steroids and o... |
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)- |
6-((7-hydroxy-5-methoxy-4-methyl-1-oxo-3h-isobenzofuran-6-yl))-4-methyl-hex-4-enoic acid 2-morpholinoethyl ester |
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester |
Cellcept |
MYCOPHENOLATE MOFETIL EP IMPURITY A (= USD RC A) |
2-(Morpholin-4-yl)ethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate |
Mycophenolate mofetil (CellCept) |
Mycophenolatemofetil |
2-morpholin-4-ylethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate |
MYCOPHENOLATE MOFITILE |
MYCOPHENOLATE |
2-(Morpholin-4-yl)ethyl-(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofur-5-yl)-4-methylhex-4-enoat |
RS 61443-190 |
MYCOPHENOLATE MOFETIL FOR PEAK IDENTIFICATION, EP STANDARD |
2-morpholin-4-ylethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate |
(E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic Acid 2-(4-Morpholinyl)ethyl Ester |
(4E)-6-(4-hydroxy-6-méthoxy-7-méthyl-3-oxo-1,3-dihydro-2-benzofur-5-yl)-4-méthylhex-4-énoate de 2-morpholin-4-yléthyle |
MYCOPHENALATE MOFETIL |
2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate |
2-(4-Morpholinyl)ethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methyl-4-hexenoate |
2-(4-Morpholinyl)ethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methyl-4-hexenoate |
MYCOPHENOLATE MOFETIL(CELLCEPT) |
(E)-2-morpholinoethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate |
2-Morpholin-4-ylethyl-(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofur-5-yl)-4-methylhex-4-enoat |
Mycophenolate mofetil |
MFCD00867568 |
Mycophenolic acid morpholinoethyl ester |